TIL that Gideon Gross together with Zelig Eshhar at the Weizmann Institute of Science, created the first chimeric antigen receptors (CARs), the basis of the development of cancer immunotherapy, involving genetic modifications of T lymphocytes extracted from cancer patients.
TIL that Gideon Gross together with Zelig Eshhar at the Weizmann Institute of Science, created the first chimeric antigen receptors (CARs), the basis of the development of cancer immunotherapy, involving genetic modifications of T lymphocytes extracted from cancer patients.
